Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody.

MLA

Sunita Gulati, et al. “Complement Alone Drives Efficacy of a Chimeric Antigonococcal Monoclonal Antibody.” PLoS Biology, vol. 17, no. 6, June 2019, p. e3000323. EBSCOhost, https://doi.org/10.1371/journal.pbio.3000323.

APA

Sunita Gulati, Frank J Beurskens, Bart-Jan de Kreuk, Marcel Roza, Bo Zheng, Rosane B DeOliveira, Jutamas Shaughnessy, Nancy A Nowak, Ronald P Taylor, Marina Botto, Xianbao He, Robin R Ingalls, Trent M Woodruff, Wen-Chao Song, Janine Schuurman, Peter A Rice, & Sanjay Ram. (2019). Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody. PLoS Biology, 17(6), e3000323. https://doi.org/10.1371/journal.pbio.3000323

Chicago

Sunita Gulati, Frank J Beurskens, Bart-Jan de Kreuk, Marcel Roza, Bo Zheng, Rosane B DeOliveira, Jutamas Shaughnessy, et al. 2019. “Complement Alone Drives Efficacy of a Chimeric Antigonococcal Monoclonal Antibody.” PLoS Biology 17 (6): e3000323. doi:10.1371/journal.pbio.3000323.